Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Photoimmunotherapy

Edelweiss: Cancer Open Access journal | Photoimmunotherapy Research articles | Open access immunotherapy treatment Articles

Photoimmunotherapy is an oncological treatment that combines photodynamic therapy of tumor with immunotherapy treatment. It is a light-based cancer therapy, Combining photodynamic therapy with immunotherapy enhances the immunostimulating response and has synergistic effects for metastatic cancer treatment.

PIT is type of molecular targeted cancer therapy, which allows the selective destruction of cancer cells without any damage to normal tissues. A variety of cancers, such as breast and pancreatic cancers over-express epidermal growth factor receptors can be treated.

Edelweiss: Cancer Open Access is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide

Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Photoimmunotherapy, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.

Related Articles

Related article links for Photoimmunotherapy will appear here as matching content is published in Edelweiss: Cancer Open Access (ISSN: 2689-6737). Readers can also browse the journal archive and current issue for connected research.

More Topics in This Journal

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Subscribe for updates

Subscribe

to get latest updates.


  Life Science

  Health Science

  Chemical Science


Subscribe